Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-03-28 to 2024-03-29
Current total value of award: $11357.4
Description: 4564115009!NUCALA 100 MG/ML SYRINGEML